Peptide storage and stability: what actually degrades a vial

Storage advice for research peptides is usually one line on a spec sheet: keep it cold, keep it dry, use it quickly. That is right, but it does not tell you why, and without the why it is impossible to judge which handling mistakes matter and which are folklore.

The short version: a lyophilised peptide is stable mostly because it is dry, not mostly because it is cold. The chemistry that destroys peptides is dominated by water and by the side chains of two specific amino acids. Everything else — freezer temperature, light, container material — modifies the rate of reactions that need water to happen at all.

The dominant pathway is deamidation, and it is sequence-dependent

Asparagine and glutamine residues carry amide side chains. In the presence of water, those side chains hydrolyse to the corresponding acid — asparagine becomes aspartate, glutamine becomes glutamate — usually via a cyclic succinimide intermediate. The molecular weight shifts by about +1 Da per event, the charge changes, and the peptide is no longer the compound on the label.

Two things about this are worth knowing when you are choosing storage conditions.

It is not uniform across peptides. Asparagine deamidates substantially faster than glutamine — Joshi and colleagues measured the relative rates directly in a glucagon fragment and found the asparagine route dominating under acidic conditions [1]. The rate also depends heavily on which residue sits immediately after the asparagine; a following glycine is the classic fast case, because it is small enough not to obstruct the succinimide ring forming.

It depends on the solvent environment, not just temperature. Brennan and Clarke showed that degradation at aspartyl and asparaginyl residues varies with the dielectric constant of the solvent [2]. That is the mechanistic reason a dry cake is stable and a reconstituted solution is not: removing bulk water does not merely dilute the reaction, it changes the environment the reaction needs.

The same chemistry shows up in the GHRH family specifically. Bongers and colleagues characterised degradation at aspartic acid and asparagine residues in human growth hormone-releasing factor and identified the specific degradation products [3]. If you are working with GHRH analogues, that paper is the one that describes what you are actually losing.

Dry does not mean inert

It is tempting to treat a lyophilised cake as chemically frozen. It is not. Lai and colleagues measured deamidation of a model hexapeptide in both hydrogels and xerogels — dried gels — and found the reaction still proceeding in the dried state, at a reduced rate [4].

The practical consequence: residual moisture in the cake matters, and so does anything that reintroduces it. Repeatedly taking a vial out of the freezer and letting it reach room temperature before opening invites condensation onto the cake. Letting a vial equilibrate to room temperature before breaking the seal is not fussiness, it is the step that keeps water out.

Reconstitution starts a clock

Once a peptide is in solution the degradation routes above run at solution rates, and new ones open. Aggregation and covalent dimerisation are the ones most likely to surprise you: Severs and colleagues found a PACAP analogue dimerising in DMSO through its asparagine and aspartic acid residues [5] — the same residues, a different failure mode, in a solvent often assumed to be inert.

That is worth sitting with. A solvent chosen precisely because it is aprotic still produced a covalent side reaction at the reactive residues. Solvent choice does not remove the problem; it selects which version of it you get.

What a certificate can and cannot tell you

A purity figure is a snapshot of the material at the moment it was tested. It says nothing about the vial in your hand after three months in a shared freezer, and no supplier can honestly claim otherwise.

What the certificate can tell you is what you started with, and that is more informative than a single percentage suggests. Purity by reversed-phase HPLC is reported as area percent, which means it is a ratio of peaks the method resolved — impurities that co-elute with the main peak are invisible to it. This is a known limitation rather than a criticism: Pichette and colleagues had to use ion-pairing reversed-phase HPLC specifically to separate a major impurity in synthetic parathyroid hormone products that ordinary conditions did not resolve [6].

More recent work makes the same point structurally. Yoshida and colleagues profiled impurities in synthetic cyclic peptides by deliberately combining hydrophilic-interaction and reversed-phase chromatography, using the orthogonality of the two methods to see what either alone would miss [7].

This is why a chromatogram is worth more than a number. The trace shows you the shape of the separation — whether the main peak is symmetric, whether anything is riding its shoulder, what the baseline is doing. A supplier who publishes the figure but not the trace is asking you to accept the one piece of the analysis that cannot be independently assessed.

Practical handling, and the reasoning behind each step

• Store lyophilised, cold, dark and sealed. The dryness is doing most of the work; the cold slows what remains.
• Equilibrate to room temperature before opening. This is about condensation, not the peptide. Water is the reagent in the reaction you are trying to avoid.
• Reconstitute what you will use. Solution-phase rates are the ones the literature above measures as fast.
• Aliquot rather than re-freeze. Freeze–thaw cycling concentrates solutes and shifts pH at the ice interface, which is a poor environment for a peptide with a reactive asparagine.
• Record the lot number. If a result looks anomalous, the lot is the only thing that lets you distinguish material from method.

That last point is the one most often skipped and the one that matters most when something goes wrong. An unexplained result in a peptide experiment has several possible sources, and the identity and purity of the starting material is the cheapest one to rule out — but only if you recorded which lot you used and the analytical record for that lot is available to you.

References

1. Joshi AB, et al. The relative rates of glutamine and asparagine deamidation in glucagon fragment 22-29 under acidic conditions. J Pharm Sci. 2002 Nov;91(11):2331-45. PMID 12379918
2. Brennan TV, et al. Spontaneous degradation of polypeptides at aspartyl and asparaginyl residues: effects of the solvent dielectric. Protein Sci. 1993 Mar;2(3):331-8. PMID 8453372
3. Bongers J, et al. Degradation of aspartic acid and asparagine residues in human growth hormone-releasing factor. Int J Pept Protein Res. 1992 Apr;39(4):364-74. PMID 1428526
4. Lai MC, et al. Deamidation of a model hexapeptide in poly(vinyl alcohol) hydrogels and xerogels. J Pept Res. 2000 Feb;55(2):93-101. PMID 10784025
5. Severs JC, et al. Dimerization of a PACAP peptide analogue in DMSO via asparagine and aspartic acid residues. J Pharm Sci. 2008 Mar;97(3):1246-56. PMID 17701959
6. Pichette A, et al. Analysis of human parathyroid hormone (1-84) products. Separation of a major impurity in synthetic products by ion-pairing reversed-phase high-performance liquid chromatography. J Chromatogr A. 2000 Aug 18;890(1):127-33. PMID 10976800
7. Yoshida K, et al. Impurity profiling of synthetic cyclic peptides based on orthogonality between hydrophilic-interaction and reversed-phase liquid chromatography. J Chromatogr A. 2025 Mar 29;1745:465748. PMID 39922152

This article describes the chemistry of peptide degradation and laboratory handling practice. It is not guidance for use in humans or animals. X Factor Peptides supplies research reference standards for in-vitro and non-clinical research only.